These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 29136407)

  • 1. Phospholipase D inhibitors reduce human prostate cancer cell proliferation and colony formation.
    Noble AR; Maitland NJ; Berney DM; Rumsby MG
    Br J Cancer; 2018 Jan; 118(2):189-199. PubMed ID: 29136407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phospholipase D2 in prostate cancer: protein expression changes with Gleason score.
    Noble AR; Hogg K; Suman R; Berney DM; Bourgoin S; Maitland NJ; Rumsby MG
    Br J Cancer; 2019 Dec; 121(12):1016-1026. PubMed ID: 31673104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phorbol ester stimulates ethanolamine release from the metastatic basal prostate cancer cell line PC3 but not from prostate epithelial cell lines LNCaP and P4E6.
    Schmitt J; Noble A; Otsuka M; Berry P; Maitland NJ; Rumsby MG
    Br J Cancer; 2014 Oct; 111(8):1646-56. PubMed ID: 25137020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased phospholipase D activity contributes to tumorigenesis in prostate cancer cell models.
    Borel M; Cuvillier O; Magne D; Mebarek S; Brizuela L
    Mol Cell Biochem; 2020 Oct; 473(1-2):263-279. PubMed ID: 32661773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The phospholipase D inhibitor FIPI potently blocks EGF-induced calcium signaling in human breast cancer cells.
    Stricker HM; Rommerswinkel N; Keil S; Gnoth SA; Niggemann B; Dittmar T
    Cell Commun Signal; 2021 Apr; 19(1):43. PubMed ID: 33832505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of phospholipases D1 and 2 in astroglial proliferation: effects of specific inhibitors and genetic deletion.
    Burkhardt U; Beyer S; Klein J
    Eur J Pharmacol; 2015 Aug; 761():398-404. PubMed ID: 25967349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. De novo steroid biosynthesis in human prostate cell lines and biopsies.
    Sakai M; Martinez-Arguelles DB; Aprikian AG; Magliocco AM; Papadopoulos V
    Prostate; 2016 May; 76(6):575-87. PubMed ID: 26841972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenotypic characterization of human prostatic stromal cells in primary cultures derived from human tissue samples.
    Gravina GL; Mancini A; Ranieri G; Di Pasquale B; Marampon F; Di Clemente L; Ricevuto E; Festuccia C
    Int J Oncol; 2013 Jun; 42(6):2116-22. PubMed ID: 23589051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostate cancer-derived exosomes promote osteoblast differentiation and activity through phospholipase D2.
    Borel M; Lollo G; Magne D; Buchet R; Brizuela L; Mebarek S
    Biochim Biophys Acta Mol Basis Dis; 2020 Dec; 1866(12):165919. PubMed ID: 32800947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and synthesis of isoform-selective phospholipase D (PLD) inhibitors. Part I: Impact of alternative halogenated privileged structures for PLD1 specificity.
    Lewis JA; Scott SA; Lavieri R; Buck JR; Selvy PE; Stoops SL; Armstrong MD; Brown HA; Lindsley CW
    Bioorg Med Chem Lett; 2009 Apr; 19(7):1916-20. PubMed ID: 19268584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trifluoroibuprofen inhibits α-methylacyl coenzyme A racemase (AMACR/P504S), reduces cancer cell proliferation and inhibits in vivo tumor growth in aggressive prostate cancer models.
    Festuccia C; Gravina GL; Mancini A; Muzi P; Cesare ED; Kirk R; Smith M; Hughes S; Gibson R; Lian LY; Ricevuto E; Carnell AJ
    Anticancer Agents Med Chem; 2014; 14(7):1031-41. PubMed ID: 24712326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two sites of action for PLD2 inhibitors: The enzyme catalytic center and an allosteric, phosphoinositide biding pocket.
    Ganesan R; Mahankali M; Alter G; Gomez-Cambronero J
    Biochim Biophys Acta; 2015 Mar; 1851(3):261-72. PubMed ID: 25532944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression analysis of thrombospondin 2 in prostate cancer and benign prostatic hyperplasia.
    Matos AR; Coutinho-Camillo CM; Thuler LC; Fonseca FP; Soares FA; Silva EA; Gimba ER
    Exp Mol Pathol; 2013 Jun; 94(3):438-44. PubMed ID: 23470460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NPRL2 enhances autophagy and the resistance to Everolimus in castration-resistant prostate cancer.
    Chen Z; Jiang Q; Zhu P; Chen Y; Xie X; Du Z; Jiang L; Tang W
    Prostate; 2019 Jan; 79(1):44-53. PubMed ID: 30178500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NCL1, a highly selective lysine-specific demethylase 1 inhibitor, suppresses prostate cancer without adverse effect.
    Etani T; Suzuki T; Naiki T; Naiki-Ito A; Ando R; Iida K; Kawai N; Tozawa K; Miyata N; Kohri K; Takahashi S
    Oncotarget; 2015 Feb; 6(5):2865-78. PubMed ID: 25605246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of 5 alpha reductase inhibitors on androgen-dependent human prostatic carcinoma cells.
    Festuccia C; Angelucci A; Gravina GL; Muzi P; Vicentini C; Bologna M
    J Cancer Res Clin Oncol; 2005 Apr; 131(4):243-54. PubMed ID: 15650886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epithelial cell adhesion molecule (EpCAM) is associated with prostate cancer metastasis and chemo/radioresistance via the PI3K/Akt/mTOR signaling pathway.
    Ni J; Cozzi P; Hao J; Beretov J; Chang L; Duan W; Shigdar S; Delprado W; Graham P; Bucci J; Kearsley J; Li Y
    Int J Biochem Cell Biol; 2013 Dec; 45(12):2736-48. PubMed ID: 24076216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoregulation of phospholipase D activity is coupled to selective induction of phospholipase D1 expression to promote invasion of breast cancer cells.
    Kang DW; Park MH; Lee YJ; Kim HS; Lindsley CW; Alex Brown H; Min do S
    Int J Cancer; 2011 Feb; 128(4):805-16. PubMed ID: 20473892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased levels of DNA methyltransferases are associated with the tumorigenic capacity of prostate cancer cells.
    Gravina GL; Ranieri G; Muzi P; Marampon F; Mancini A; Di Pasquale B; Di Clemente L; Dolo V; D'Alessandro AM; Festuccia C
    Oncol Rep; 2013 Mar; 29(3):1189-95. PubMed ID: 23254386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of an anabolic selective androgen receptor modulator that actively induces death of androgen-independent prostate cancer cells.
    Schmidt A; Meissner RS; Gentile MA; Chisamore MJ; Opas EE; Scafonas A; Cusick TE; Gambone C; Pennypacker B; Hodor P; Perkins JJ; Bai C; Ferraro D; Bettoun DJ; Wilkinson HA; Alves SE; Flores O; Ray WJ
    J Steroid Biochem Mol Biol; 2014 Sep; 143():29-39. PubMed ID: 24565564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.